Drug Trial Radar · NCT06365437
A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation
Last checked: Nov 20, 2026Latest source record: Mar 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
33
Actual
Start
Jun 6, 2021
Primary completion
Dec 11, 2024
Study completion Dec 11, 2024
Sponsor
- Lead sponsor
- ITB-Med LLCIndustry
- Sponsor type
- Industry
- First posted
- Apr 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of escalating doses of TCD601 when compared to rATG in de novo renal transplant patients.
Conditions
- Kidney Transplantation
Interventions
TCD601Biological
Investigational Product
Tacrolimus (TAC)Drug
Standard of Care Concomitant Immunosuppression
Corticosteroids (CS)Drug
Standard of Care Concomitant Immunosuppression
Mycophenolate Mofetil (MMF)Drug
Standard of Care Concomitant Immunosuppression
ATGDrug
Standard of Care induction therapy in solid organ transplantation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v5.0.Time frame: 12 months
- Measure Peak TCD601 Plasma Concentration (Cmax) Over Time.Time frame: 12 months
- Measure the Area Under the TCD601 Plasma Concentration Versus Time Curve (AUC).Time frame: 12 months
Locations
7 sites in 3 countries. Site status is shown where the registry gives one.
Innsbruck Medical University
Innsbruck, Austria
University of Vienna
Vienna, Austria
Hospital Clinic de Barcelona
Barcelona, Spain
Hospital Universitari de Bellvitge
Barcelona, Spain
Sahlgrenska University Hospital
Gothenburg, Sweden
Skåne University Hospital
Malmö, Sweden
Karolinska University Hospital
Stockholm, Huddinge, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.